Literature DB >> 25743484

Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.

Junko Akaishi1, Kiminori Sugino, Kaori Kameyama, Chie Masaki, Kenichi Matsuzu, Akifumi Suzuki, Takashi Uruno, Keiko Ohkuwa, Hiroshi Shibuya, Wataru Kitagawa, Mitsuji Nagahama, Kazuo Shimizu, Koichi Ito.   

Abstract

BACKGROUND: Diffuse sclerosing variant (DSV) of papillary thyroid carcinoma (PTC) is a rare variant more common among younger patients.
MATERIALS AND METHODS: Excluding patients with microcarcinoma, 5848 patients with PTC underwent initial surgery between 1995 and 2011. Twenty-two patients (0.4 %) were histologically diagnosed with DSV, of whom 20 (91 %) were <45 years old. We compared clinicopathologic characteristics and outcomes between patients with DSV and those with classical PTC <45 years old. Univariate analysis by the Kaplan-Meier method in relation to cause-specific survival (CSS) and disease-free survival (DFS) rates was performed with regard to the following variables: sex; anti-thyroglobulin antibody (TgAb) positivity; presence of distant metastasis; pathological lymph node metastasis; extra-thyroidal invasion; and pathological variant (classical vs. DSV).
RESULTS: The 20 patients with DSV <45 years old comprised 18 females and 2 males. Frequencies of TgAb, pN1b, and local recurrence were higher in the DSV group than in the classical PTC group. Ten-year CSS and DFS rates for PTC patients <45 years old were 99.7 and 88.6 % in the classical PTC group and 100 and 60.5 % in the DSV group. CSS rate did not differ between groups, but DFS rate was significantly lower in the DSV group than in the classical PTC group (p < 0.0001, log-rank test). Multivariate analysis identified DSV group and pN1b as prognostic factors for recurrence in young PTC patients.
CONCLUSIONS: Most DSV patients were young and had a background of chronic thyroiditis. Outcomes for DSV were very good, but recurrence was more common than in classical PTC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25743484     DOI: 10.1007/s00268-015-3021-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis.

Authors:  S Schröder; V Bay; K Dumke; B Kremens; H W Müller-Gärtner; W Böcker; H Kastendieck
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Diffuse sclerosing variant of papillary carcinoma of the thyroid. A histopathological study of four cases.

Authors:  Y Hayashi; T Sasao; N Takeichi; K Kuma; S Katayama
Journal:  Acta Pathol Jpn       Date:  1990-03

3.  Variants of papillary carcinoma of the thyroid: experience at Asir Central Hospital.

Authors:  A R Khan; S A Abu-Eshy
Journal:  J R Coll Surg Edinb       Date:  1998-02

4.  Revisiting the guidelines issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: a gradual move towards consensus between Japanese and western practice in the management of thyroid carcinoma.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Naoyoshi Onoda; Hitoshi Noguchi; Akira Yoshida
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

5.  A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases.

Authors:  Concetto Regalbuto; Pasqualino Malandrino; Andrea Tumminia; Rosario Le Moli; Riccardo Vigneri; Vincenzo Pezzino
Journal:  Thyroid       Date:  2011-04       Impact factor: 6.568

6.  Diffuse sclerosing variant of papillary thyroid carcinoma: case report and review of the literature.

Authors:  R H Caplan; S Wester; A W Kisken
Journal:  Endocr Pract       Date:  1997 Sep-Oct       Impact factor: 3.443

7.  Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid.

Authors:  M Albareda; M Puig-Domingo; S Wengrowicz; J Soldevila; X Matias-Guiu; A Caballero; A Chico; A De Leiva
Journal:  Thyroid       Date:  1998-05       Impact factor: 6.568

8.  Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid.

Authors:  Y Imamura; Y Kasahara; M Fukuda
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

Review 9.  Clinicopathological study of the diffuse sclerosing variety of papillary cancer of the thyroid. Presentation of 4 new cases and review of the literature.

Authors:  A Moreno Egea; J M Rodriguez Gonzalez; J Sola Perez; T Soria; P Parrilla Paricio
Journal:  Eur J Surg Oncol       Date:  1994-02       Impact factor: 4.424

10.  Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases.

Authors:  J Soares; E Limbert; M Sobrinho-Simões
Journal:  Pathol Res Pract       Date:  1989-08       Impact factor: 3.250

View more
  8 in total

1.  Surgical Management of Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma. Experience in 25 Patients.

Authors:  Claudio Spinelli; Silvia Strambi; Sohail Bakkar; Andrea Nosiglia; GianMarco Elia; Alessia Bertocchini; Chiara Calani; Matteo Leoni; Riccardo Morganti; Gabriele Materazzi
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

2.  Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.

Authors:  Jianhua Feng; Fei Shen; Wensong Cai; Xiaoxiong Gan; Xingyan Deng; Bo Xu
Journal:  Endocrine       Date:  2018-06-16       Impact factor: 3.633

3.  Shear wave elastography diagnosis of the diffuse sclerosing variant of papillary thyroid carcinoma: A case report.

Authors:  Nianyu Xue; Youfeng Xu; Pintong Huang; Shengmin Zhang; Hongwei Wang; Fei Yu
Journal:  Mol Clin Oncol       Date:  2016-06-13

4.  The role of laryngectomy in locally advanced thyroid carcinoma. Review of 16 cases.

Authors:  A I Chala; S Vélez; A Sanabria
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

5.  Diffuse sclerosing variant of papillary thyroid carcinoma: outcomes of 33 cases.

Authors:  Daniela Cavaco; Ana Filipa Martins; Rafael Cabrera; Helena Vilar; Valeriano Leite
Journal:  Eur Thyroid J       Date:  2022-01-19

6.  Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine-needle aspiration cytology, BRAFV600E , and ultrasound elastography.

Authors:  Xian Wang; Feiju Xu; Juan Gao; Enock Adjei Agyekum; Hui Sun; Guoliang Zhang; Xinxin Li; Hong Xiang; Shudong Hu; Xiaoqin Qian
Journal:  J Clin Ultrasound       Date:  2022-07-02       Impact factor: 0.869

7.  Papillary Thyroid Carcinoma Tissue miR-146b, -21, -221, -222, -181b Expression in Relation with Clinicopathological Features.

Authors:  Aistė Kondrotienė; Albertas Daukša; Daina Pamedytytė; Mintautė Kazokaitė; Aurelija Žvirblienė; Dalia Daukšienė; Vaida Simanavičienė; Raimonda Klimaitė; Ieva Golubickaitė; Rytis Stakaitis; Valdas Šarauskas; Rasa Verkauskienė; Birutė Žilaitienė
Journal:  Diagnostics (Basel)       Date:  2021-03-02

8.  Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study.

Authors:  Mijin Kim; Sun Wook Cho; Young Joo Park; Hwa Young Ahn; Hee Sung Kim; Yong Joon Suh; Dughyun Choi; Bu Kyung Kim; Go Eun Yang; Il-Seok Park; Ka Hee Yi; Chan Kwon Jung; Bo Hyun Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.